Back
ESC Premium Access

Pre-operative liver dysfunction is associated with higher mortality rates at 1-year after left ventricular assist device implantation.

Session: Predictors of outcome after LVAD implantation
Topic: Ventricular Assist Devices
Speaker: Mr R. Muslem (Rotterdam, NL)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Mr Rahat Muslem

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

6 more presentations in this session

Expression levels of cTnTs and TnI were modified in the heart of pediatric and adults heart failure (HF) patients after ventricular assist device (VAD) implant

Speaker: Doctor C. Caselli (Pisa, IT)

Access
Abstract
Like
Thumbnail

Disparities in decisional regret among left ventricular assist device patient and caregiver recipients

Speaker: Doctor E. Stahl (Atlanta, US)

Access
Abstract
Slides
Like
Thumbnail

Changes in plasma neprilysin levels after left ventricular assist device implantation and association with short-term outcomes

Speaker: Doctor E. Yuce (Izmir, TR)

Access
Abstract
Slides
Like
Thumbnail

Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome.

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Access
Abstract
Slides
Like
Thumbnail

Invasive exercise haemodynamics predict functional capacity in patients with advanced heart failure implanted with a left ventricular assist device

Speaker: Doctor A. Koshy (Leeds, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Predictors of outcome after LVAD implantation

Speakers: Mr R. Muslem, Doctor C. Caselli, Doctor E. Stahl, Doctor E. Yuce, Doctor M. Vanderheyden...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources